0 NYSE Companies - April 8, 2024Fortuna reports strong gold equivalent production of 112,543 ounces in the first quarter of 2024VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports strong gold […]Read More
0 NASDAQ Companies - April 8, 2024Synaptics Astra™ AI-Native IoT Platform Launches with SL-Series Embedded Processors and Machina Foundation Series Development KitSAN JOSE, Calif., April 08, 2024 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today launched the Synaptics Astra platform with […]Read More
0 NASDAQ Companies - April 8, 2024WTW announces appointment of Sean Plankey as Global Leader Cybersecurity SoftwareLONDON, April 08, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced […]Read More
0 TSX News - April 8, 2024Wesdome Provides Kiena Exploration Update; Drilling Continues to Grow Kiena Deep and Intercept High Grades Near Mine InfrastructureTORONTO, April 08, 2024 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) today […]Read More
0 TSX Venture News - April 8, 2024SIRONA BIOCHEM Corporate Update April 2024VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or […]Read More
0 NYSE Companies - April 8, 2024Caledonia Mining Corporation Plc: Appointment of Chief Operating OfficerST HELIER, Jersey, April 08, 2024 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: […]Read More
0 NYSE Companies - April 8, 2024La Dette à Long Terme de CGG Revue à la Hausse par S&P Paris, France – le 8 avril 2024 CGG annonce aujourd’hui que S&P Global Ratings (” S&P”) a relevé la note […]Read More
0 NYSE Companies - April 8, 2024CGG’s Long Term Debt Upgraded by S&PPARIS, France – April 8, 2024 CGG today announced that S&P Global Ratings (“S&P”) has upgraded the Company’s issuer credit […]Read More
0 NASDAQ Companies - April 8, 2024Pharming announces completion of enrollment in pediatric clinical trial of leniolisibThis multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare […]Read More